Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(7)
MIXED(6)
DRUG(5)
IM96 CAR-T Cells
2 trials
phase_1
beijing-immunochina-medical-science-technology-co-ltd
BL-B01D1
2 trials
phase_1phase_3
sichuan-baili-pharmaceutical-co-ltd
paclitaxel
1 trial
phase_3
sichuan-baili-pharmaceutical-co-ltd
IIC2：3E9 PFU of oncolytic virus, early combination
1 trial
early_phase_1
peking-university
Claudin18.2-Targeted Chimeric Antigen Receptor T Cell Injection
1 trial
phase_1
peking-university
IIA1：1E9 PFU of oncolytic virus, sequentially combination
1 trial
early_phase_1
peking-university
IID：3E9 PFU of oncolytic virus, Immuno-Oncology free combination
1 trial
early_phase_1
peking-university
docetaxel
1 trial
phase_3
sichuan-baili-pharmaceutical-co-ltd

+8 more interventions

16 unique interventions3 categories

Analytics

Trial Phases

Phase 17
Phase 21
Phase 31

Trial Status

Completed1
Recruiting5
Other4

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT06380309Early Phase 1Recruiting
A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE
Advanced Malignant Solid Tumor of Digestive System
PrincipalinvestigatorStart date: 2024-05-06
NCT06349811Phase 1Recruiting
A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors
Locally Advanced or Metastatic Solid Tumors
PrincipalinvestigatorStart date: 2024-04-19
NCT06304974Phase 3Active Not Recruiting
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)
Esophageal Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2024-03-19
NCT05981235Phase 1Completed
Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors
Gastrointestinal Tumors
PrincipalinvestigatorStart date: 2023-12-14
NCT06353152Phase 1Unknown
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
PrincipalinvestigatorStart date: 2023-11-17
NCT05950815Phase 1Unknown
A Study of PM1015 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
PrincipalinvestigatorStart date: 2022-05-10
NCT05262491Phase 1Recruiting
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
Gastrointestinal Tumor
PrincipalinvestigatorStart date: 2022-02-14
NCT03736889Phase 2Recruiting
Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors
MSI-H/dMMR Solid Tumors
PrincipalinvestigatorStart date: 2018-09-19
NCT06718738Phase 1Recruiting
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer
Colorectal Cancer (CRC)
Principalinvestigator
NCT07406984Phase 1Not Yet Recruiting
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction
Adenocarcinoma of Esophagogastric JunctionAdenocarcinoma of Gastric
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Advanced Solid TumorEsophageal Squamous Cell CarcinomaGastric Adenocarcinoma+1 more

Worked with same sponsors:

Peking UniversityPeking University Cancer Hospital & Institute
Similarity Score10%

lin shen, Professor

Peking University Cancer Hospital & Institute

Related
10 trials

Shared therapeutic areas:

Esophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma

Worked with same sponsors:

Peking UniversityPeking University Cancer Hospital & Institute
Similarity Score8%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Esophageal Squamous Cell CarcinomaGastric Adenocarcinoma
Similarity Score5%

Yelena Janjigian, MD

Memorial Sloan Kettering Cancer Center

Related
12 trials

Shared therapeutic areas:

Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Similarity Score5%

Ruihua Xu, MD

Sun Yat-sen University

Related
9 trials

Shared therapeutic areas:

Advanced Solid TumorEsophageal Squamous Cell Carcinoma
Similarity Score5%

Anish Thomas, M.D.

National Cancer Institute (NCI)

Related
9 trials

Shared therapeutic areas:

Advanced Solid Tumor
Similarity Score3%

Jane Robertson

AstraZeneca

Related
10 trials

Shared therapeutic areas:

Advanced Solid Tumor

Worked with same sponsors:

AstraZeneca
Similarity Score3%

Shun Lu

Shanghai Chest Hospital

Related
6 trials

Shared therapeutic areas:

Advanced Solid Tumor
Similarity Score3%

Javier Martín Broto

Hospital Universitario Fundación Jiménez Díaz

Related
5 trials

Shared therapeutic areas:

Advanced Solid Tumor
Similarity Score3%

Richard Kim, M.D.

H. Lee Moffitt Cancer Center and Research Institute

Related
11 trials

Shared therapeutic areas:

Gastrointestinal Tumor
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT06380309Early Phase 1PrincipalInvestigator

A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE

Advanced Malignant Solid Tumor of Digestive System
Recruiting
NCT06349811Phase 1PrincipalInvestigator

A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors
Recruiting
NCT06304974Phase 3PrincipalInvestigator

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)

Esophageal Squamous Cell Carcinoma
Active Not Recruiting
NCT05981235Phase 1PrincipalInvestigator

Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors

Gastrointestinal Tumors
Completed
NCT06353152Phase 1PrincipalInvestigator

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma

Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Unknown
NCT05950815Phase 1PrincipalInvestigator

A Study of PM1015 in Patients With Advanced Solid Tumors

Advanced Solid Tumor
Unknown
NCT05262491Phase 1PrincipalInvestigator

A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor

Gastrointestinal Tumor
Recruiting
NCT03736889Phase 2PrincipalInvestigator

Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors

MSI-H/dMMR Solid Tumors
Recruiting
NCT06718738Phase 1PrincipalInvestigator

Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer

Colorectal Cancer (CRC)
Recruiting
NCT07406984Phase 1PrincipalInvestigator

Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction

Adenocarcinoma of Esophagogastric JunctionAdenocarcinoma of Gastric
Not Yet Recruiting

All 10 trials loaded